To Top

Search By Topic

Drug discovery

100 Articles available
PTSD

The VA Recognizes Ketamine as an Emergency Treatment for PTSD and Depression Patients at High Suicide Risk

PR-M10-18-NI-012
Drug Development

Bayer Gets FDA Approval for Hemophilia A Drug

PAO-M09-18-NI-006
Research

Researchers Make Discovery about Leptin Resistance

PAO-M08-18-NI-025
CRO

From Internal Lab to External Service Provider

PAO-M08-18-NI-009
Clinical Data

Pulmatrix Announces Positive Top-Line Preliminary Results from Part 3 of the 3-Part Phase 1/1b Clinical Trial of Pulmazole

PR-M07-18-NI-058
Drug Development

New Antibiotic to be Tested against Potential Bioweapons

PAO-M07-18-NI-009
Drug Discovery

Could a Bispecific Antibody Be A Functional Cure for AIDS?

PAO-M06-18-NI-015
Drug Approval

WuXi STA First CDMO to Support the Approval of an Innovative Drug in China Through the "MAH" Pilot

PR-M06-18-NI-057
Drug Discovery

Eisai Inc. to Launch Center for Genetics Guided Dementia Discovery in Cambridge, Massachusetts

PR-M06-18-NI-044
Artificial Intelligence

WuXi AppTec Leads Strategic Investment in Insilico Medicine to Accelerate Drug Discovery Using Next-Generation Artificial Intelligence

PR-M06-18-NI-037
Clinical Data

New Data Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication

PR-M06-18-NI-030
R&D

Researchers Find Link between Tuberculosis and Parkinson’s Disease

PAO-M05-18-NI-025
Inhalation

GSK Applies in Japan for Approval of a Once-Daily, Single Inhaler Triple Therapy for COPD

PAO-M05-18-NI-022
Next-Generation Manufacturing

Thinking a Generation Ahead: Biologics-Based Therapy

PAP-Q2-18-FA-002
Fast Track

Valneva Receives Fast Track Designation for Lyme Disease Vaccine

PAO-M05-18-NI-021
Drug Discovery

RNA-Modifying Proteins May Provide New Drug Targets

PAO-M05-18-NI-018
Treatment

New Single-Pill HIV Treatment Approved in Europe

PAO-M05-18-NI-015
Drug Development

Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis

PR-M05-18-NI-060
Drug Discovery

XtalPi Inc. Announces Strategic Research Collaboration with Pfizer Inc. to Develop Artificial Intelligence-Powered Molecular Modeling Technology for Drug Discovery

PR-M05-18-NI-041
Inflammatory Disease

Gilead Sciences and Verily Life Sciences LLC Enter Collaboration, Hope to Better Understand Inflammatory Diseases

PAO-M05-18-NI-002
Approval

Fresenius Kabi Announces New Approval and Immediate Availability of Daptomycin for Injection

PR-M04-18-NI-58
Drug Discovery

"Transcriptional wiring" of cancer genes can be resolved using Lexogen's SLAMseq and QuantSeq technologies to facilitate drug discovery

PR-M04-18-NI-38
Laboratory Testing

Creating Comprehensive Solutions through Laboratory Testing

PAP-Q1-18-CL-011
Innovation

LYNPARZA® (olaparib) Receives Positive EU CHMP Opinion in Platinum-Sensitive Relapsed Ovarian Cancer

PR-M02-18-NI-100
Oncology

Pfizer Receives Positive CHMP Opinion for Two Hematology Medicines, MYLOTARG™and BOSULIF®

PR-M02-18-NI-98
Clinical Data

Bayer Announces Publication of Larotrectinib Data in The New England Journal of Medicine

PR-M02-18-NI-97
Acquistion

Allergen Acquires Elastagen

PAO-M02-18-NI-012
Joint Venture

DSM and Evonik Establish Veramaris Joint Venture

PR-M02-18-NI-024
Immuno-Oncology

Syndax Announces Immuno-Oncology Clinical Trial Collaboration with AstraZeneca

PR-M02-18-NI-020
Financing

Engine Biosciences Raises $10 Million in Seed Financing to Accelerate Drug Discovery Using Genomics and Artificial Intelligence

PR-M02-18-NI-015
Contract

Prime Therapeutics and Boehringer Ingelheim Enter Into Outcomes-Based Contract for Jardiance®

PR-M02-18-NI-013
Oncology

Stand Up To Cancer Announces $11M Collaborative, Multi-Disciplinary Research Program

PR-M02-18-NI-010
Discovery

Scientists Discover How Gene Mutation Triggers Immune Disease

PR-M02-18-NI-008
Oncology

Stopping Cancer Cell Division Using Targeted Enzyme Control

PAO-M02-18-NI-001
Biosimilars

Novartis Makes More Biosimilar Moves

PAO-M01-18-NI-047
Vaccine

EMA Committee Gives Positive Recommendation to GSK’s Shingles Vaccine

PAO-M01-18-NI-046
CAR-T

Pfizer Joins Gilead in CAR-T Development   

PAO-M01-18-NI-044
Drug Discovery

X-Chem Enters Expanded Global Drug Discovery and Technology Transfer Collaboration with AstraZeneca

PR-M01-18-NI-073
Biosimilar

European Commission Approves Amgen And Allergan's MVASI® (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer

PR-M01-18-NI-077
Bioprinting

Sebaceous Glands in 3D

PAO-M01-18-NI-029
Pulmonx

Pulmonx Submits Premarket Approval (PMA) Application to U.S. FDA for Zephyr Endobronchial Valve as Treatment for Emphysema

PR-M01-18-NI-039
Strategic Collaboration

Syapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in Oncology

PR-M01-18-NI-033
Development Agreement

Arvinas Protein Degradation Technology Attracts Pfizer’s Attention

PAO-M01-18-NI-020
Cannibis

California Legalizes Cannabis with Canada Looming

PR-M01-18-NI-030
Oncology Research

Global BioLife, a Biomedical Subsidiary of Singapore eDevelopment Limited, Completes Cancer Research for New Universal Therapeutic Drug Platform

PR-M01-18-NI-028
Biologics

New Class of Exosome Biologics Focuses on Stroke Treatment

PAO-M01-18-NI-011
Drug Discovery

Defense Department Commits $16 Million to Fight Bacterial Bioweapons

PAO-M01-18-NI-010
Business

Expansion Therapeutics Raises $55.3 Million in Series A Financing to Advance Portfolio of Novel RNA Targeted Small Molecule Medicines to Treat Rare Diseases

PR-M01-18-NI-009
Acquisition

Gilead’s new Kite Subsidiary To Buy CAR-T Cell Therapy Company Cell Design Labs

PAO-M01-18-NI-001
Biosimilars

Pfizer Receives FDA Approval for Remicade® Biosimilar

PAO-M12-17-NI-039
DNA

New Method Could Provide Super Resolution for Biological Imaging

PAO-M12-17-NI-040
Chemistry

Hot Electrons Might Enable New Synthetic Methods

PAO-M12-17-NI-039
Drug Delivery

Needle-Free Injection Technology Advances to Phase II Trial

PAO-M12-17-NI-035
Artificial Intelligence

New Platform Brings AI Efficiency to Health Data Processing

PAO-M12-17-NI-036
Investment

Transporters Targeting Cell’s Metabolic Gates Win Financing

PAO-M12-17-NI-037
Drug Delivery

Needle-Free Injection Technology Advances to Phase II Trial

PAO-M12-17-NI-035
FDA

NDA Submitted for Antimalarial Drug

PAO-M12-17-NI-034
Oncology

CMC Biologics Announces Agreement

PAO-M12-17-NI-032
Added Capacity

World’s Largest Biologics Plant Gets EMA Nod

PAO-M12-17-NI-029
Innovation

Renova Therapeutics' Gene Transfer Tech Enters the Fast Lane

PAO-M12-17-NI-028
Vaccine

Viral Vaccine Development Gets Major Boost from xCELLigence RTCA

PR-M12-17-NI-012
Oncology

Phase III Study Confirms AbbVie Leukemia Combo Meets Endpoint

PAO-M12-17-NI-021
Drug Development

New Generic for Kenalog-40 Approved

PAO-M12-17-NI-020
Diabetes

First “Follow-On” Insulin Product Approved

PAO-M12-17-NI-019
Biosimilars

First Biosimilar to Treat Breast and Stomach Cancers Approved

PAO-M12-17-NI-007
Regenerative Medicine

International Society for Cellular Therapy Supports New FDA Policy Framework for Regenerative Medicine

PAO-M12-17-NI-004
Drug Development

Thermo Fisher Scientific’s Patheon Division to Manufacture Nasal Formulation for Evoke Pharma

PAO-M12-17-NI-003
Strategic Partnership

New Collaboration Targets the Development of Oligonucleotides

PAO-M12-17-NI-002
Innovation

Single-Pill, HIV-1 Combination Therapy Approved

PAO-M11-17-NI-050
Discovery

Boehringer Ingelheim and HitGen Enter Drug Discovery Collaboration

PAO-M11-17-NI-049
Non-Opioid

SiteOne Therapeutics Garners US Department of Defense Award

PAO-M11-17-NI-036
Biologics

Collaboration Announced Between Takeda Pharmaceutical and Portal Instruments

PAO-M11-17-NI-035
Antibiotics

Simplified Versions of Teixobactin Could Be Commercialized

PAO-M11-17-NI-034
Drug Development

New Malaria Therapeutic Receives FDA Orphan Drug Designation

PAO-M11-17-NI-028
Drug Discovery

Novel Compound Developed That Could Serve as a Non-Addictive Opiod Alternative

PAO-M11-17-NI-027
Strategic Partnership

Dicerna and Boehringer Ingelheim Ink Deal to Develop Treatments for Chronic Liver Diseases

PAO-M11-17-NI-022
Drug Development

NIH Funds Bacterial DNA Superbug Killer

PAO-M11-17-NI-014
Drug Development

Amgen and Novartis Expand Collaboration to Prevent Alzheimer’s

PAO-M11-17-NI-009
Immuno-oncology

Immuno-oncology Approach Based on Electronic Circuitry

PAO-M11-17-NI-008
CRISPR

CRISPR Technology Could Enable New Treatments for Resistant Fungal Infections

PAO-M11-17-NI-006
Drug Discovery

Forge Therapeutics and Evotec Expand Their Partnership

PAO-M10-17-NI-041
Medical Application

Smart Phone Compatible Cardiac Monitor Launched

PAO-M10-17-NI-038
Stem Cell Therapy

Aging Frailty Stem Cell Therapy Advances

PAO-M10-17-NI-025
Clinical Trials

Greenovation Biotech GmbH Announces Completion Of Its Phase I Safety Study For moss-aGal Targeting Fabry Disease

PR-M10-17-NI-005
Vaccine

Merck, J&J Receive BARDA Funding for Ebola Vaccine Development

PAO-M10-17-NI-019
Innovation

Modeling Mechanisms for Crossing the Blood-Brain Barrier

PAO-M09-17-NI-033
Innovation

Potential Breakthrough HIV/AIDS Intervention Developed

PAO-M09-17-NI-035
Innovation

Alliance Aims to Develop Novel Mass Spectrometry Sample Handling Technology

PAO-M09-17-NI-031
Clinical Trials

Findings Suggest Low-Cal Sweeteners Pose No Increased Diabetes Risk

PAO-M09-17-NI-023
Big Data

Big Data Alliance Aims to Advance Cancer Treatments

PAO-M09-17-NI-021
Antibiotics

New Class of Antibiotics Looks Promising

PAO-M07-17-NI-017
Drug Discovery

Bio-Rad on the Road to BIO: Accelerating Discovery to Improve Lives

Steven Blakely, Global Director of Marketing, Drug Discovery & Development Business, Bio-Rad. View more about Bio-Rad on the Road to BIO.

 

PTV-M06-17-CL-014
Innovation

3D Patch Reduces Ischemia in Mouse Models

PAO-M06-17-NI-011
Drug Discovery

Disease-In-A-Dish: Leveraging in vitro Human Models to Advance Drug Discovery

PAP-Q2-17-CL-006
Innovation

From Blobs to Hearts: Understanding the 3D Bioprinting Revolution

PAP-Q2-17-TT-001